Obsessive-Compulsive Disorder Clinical Trials in Stanford, California

5 studies are recruiting for obsessive-compulsive disorder in Stanford, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of Dextromethorphan in OCD and Related Disorders

    The purpose of the study is to assess the tolerability and efficacy of dextromethorphan in combination with fluoxetine for symptom relief in OCD and related disorders.

    Stage
    Phase 2
    Ages
    18 to 65
    Site
    Stanford University, Stanford, California
    Run by
    Stanford University

    See if you can join NCT04899687 on ClinicalTrials.gov

  2. SEEG-Guided DBS for OCD

    This is a multi-site, double-blinded, randomized, crossover study design for SEEG-guided 4-lead DBS for treatment-refractory OCD, followed by open-label stimulation for an additional 6 months. The study will be conducted in 3 stages: Stage 1 will consist of SEEG brain mapping and optimization of st…

    Stage
    Not phased
    Ages
    22 to 75
    Site
    Stanford University, Stanford, California
    Locations
    2 in total
    Run by
    Casey H. Halpern, M.D.

    See if you can join NCT05623306 on ClinicalTrials.gov

  3. Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

    The purpose of this study is to understand how ketamine works in the brain to bring about a reduction in OCD symptoms.

    Stage
    Phase 2
    Ages
    18 to 65
    Site
    Department of Psychiatry & Behavioral Sciences, Stanford, California
    Run by
    Stanford University

    See if you can join NCT05940324 on ClinicalTrials.gov

  4. Caloric Vestibular Stimulation for Modulation of Insight in Obsessive-Compulsive Spectrum Disorders

    This study investigates whether caloric vestibular stimulation can modulate a measure of insight in obsessive-compulsive spectrum disorders.

    Stage
    Not phased
    Ages
    18 to 65
    Site
    Stanford University, Stanford, California
    Run by
    Stanford University

    See if you can join NCT03918577 on ClinicalTrials.gov

  5. Efficacy of Nitrous Oxide in OCD: Pilot Study

    This study investigates whether the commonly used and well-tolerated inhaled anesthetic nitrous oxide can rapidly improve symptoms of OCD.

    Stage
    Phase 2
    Ages
    18 to 65
    Site
    Stanford University, Stanford, California
    Run by
    Stanford University

    See if you can join NCT03826693 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.